MMS Submission Support for Paratek Pharmaceuticals Garners FDA Approval and Successful MAA Filing of NUZYRA™ (Omadacycline)CANTON, Mich. (October 11, 2018) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today their expert support to...
CANTON, Mich. (October 5, 2018) – MMS Holdings Inc. (MMS) – award-winning, data-focused CRO – announced today its renewed dedication to the local communities surrounding Detroit and Ann Arbor by allocating a substantial amount of colleague time to volunteer...
UNITED KINGDOM (August 23, 2018) – MMS Holdings Inc. (MMS) – an award-winning, global clinical research organization – announced today that it has won the award for Best Global Biotech CRO in the International Life Sciences Awards 2018 by Global Health & Pharma...
This Saturday, MMS is hosting their annual Scientific Symposium India at its Asian headquarters in Bangalore, India. RSVP now at: Asia@mmsholdings.com AGENDA 9:30am: Ice Breaker – Deepthi Rajan Morning Address – Uma Sharma, Ph.D. Morning Activity – Deepthi Rajan...
Canton, Mich. (July 10, 2018) – MMS Holdings Inc. (MMS) – a global, leading clinical research organization – announced today its integrated support for Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and...
Durham, N.C. (June 13, 2018) – MMS Holdings Inc. (MMS) – a leading global clinical research organization – announced today that Lisa James has joined as Director, Business Operations and Client Relations. James brings a depth of industry and business experience,...
Is among the lowest attrition rates in the pharmaceutical industry regionally Bangalore, India (June 7, 2018) – MMS Holdings Inc. (MMS) – a global, leading clinical research organization – announced today two major promotions at its Asia headquarters, including Dr....
Canton, Mich. and Findlay, Ohio (May 1, 2018) – MMS Holdings Inc. (MMS) – a global, leading clinical research organization – announced today that they have partnered with the University of Findlay to provide online medical writing and clinical trial disclosures...
Canton, Mich. (April 13, 2018) – MMS Holdings Inc. (MMS) – a global, leading clinical research organization – announced today that it has surpassed a training milestone, now with more than 700 training courses available in their learning management system. This...